Tian Jin Bohai Chemical Co.,Ltd. (SHA:600800)
China · Delayed Price · Currency is CNY 4.800
+0.050 (1.05%)
Apr 14, 2026, 3:00 PM CST
Tian Jin Bohai Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,330 | 4,783 | 3,225 | 6,047 | 4,246 |
Other Revenue | - | 0.64 | 0.29 | 0.64 | 0.5 |
| 3,330 | 4,784 | 3,225 | 6,048 | 4,247 | |
Revenue Growth (YoY) | -30.39% | 48.31% | -46.67% | 42.42% | 55.29% |
Cost of Revenue | 3,999 | 5,162 | 3,559 | 5,678 | 3,784 |
Gross Profit | -669.2 | -378.26 | -334.02 | 370.32 | 462.56 |
Selling, General & Admin | - | 138.92 | 103.18 | 118.61 | 115.72 |
Research & Development | - | 154.34 | 172.61 | 200.5 | 70.82 |
Other Operating Expenses | - | -27.25 | 12.31 | 30.79 | 25.81 |
Operating Expenses | - | 265.94 | 285.44 | 334.79 | 217.2 |
Operating Income | -669.2 | -644.2 | -619.46 | 35.53 | 245.36 |
Interest Expense | - | -52.73 | -37.66 | -49.22 | -32.78 |
Interest & Investment Income | - | 14.8 | 19.18 | 14.5 | 13.07 |
Currency Exchange Gain (Loss) | - | -0.96 | -6.82 | -35.87 | 6.41 |
Other Non Operating Income (Expenses) | 24.37 | -5.26 | 20.76 | -10.22 | -15.79 |
EBT Excluding Unusual Items | -644.83 | -688.35 | -624.01 | -45.28 | 216.26 |
Merger & Restructuring Charges | - | - | -0.63 | -0.99 | - |
Gain (Loss) on Sale of Investments | - | -1.57 | 1.15 | -1.29 | 1.25 |
Gain (Loss) on Sale of Assets | - | 96.51 | -0.41 | - | -0.02 |
Asset Writedown | - | 0 | - | - | - |
Legal Settlements | - | -0.01 | -0.01 | -1.09 | - |
Other Unusual Items | - | -38.34 | 0.55 | 4.13 | 15 |
Pretax Income | -644.83 | -631.76 | -623.34 | -44.53 | 232.49 |
Income Tax Expense | 1.51 | 0.25 | -102.33 | -6.29 | 44.7 |
Earnings From Continuing Operations | -646.34 | -632.01 | -521.01 | -38.24 | 187.79 |
Minority Interest in Earnings | - | -0.14 | - | - | - |
Net Income | -646.34 | -632.14 | -521.01 | -38.24 | 187.79 |
Net Income to Common | -646.34 | -632.14 | -521.01 | -38.24 | 187.79 |
Net Income Growth | - | - | - | - | 0.95% |
Shares Outstanding (Basic) | 1,114 | 1,109 | 1,184 | 1,275 | 1,174 |
Shares Outstanding (Diluted) | 1,114 | 1,109 | 1,184 | 1,275 | 1,174 |
Shares Change (YoY) | 0.48% | -6.34% | -7.10% | 8.60% | 19.88% |
EPS (Basic) | -0.58 | -0.57 | -0.44 | -0.03 | 0.16 |
EPS (Diluted) | -0.58 | -0.57 | -0.44 | -0.03 | 0.16 |
EPS Growth | - | - | - | - | -15.79% |
Free Cash Flow | - | -180.22 | -566.42 | 579.4 | 266.25 |
Free Cash Flow Per Share | - | -0.16 | -0.48 | 0.46 | 0.23 |
Gross Margin | -20.10% | -7.91% | -10.36% | 6.12% | 10.89% |
Operating Margin | -20.10% | -13.47% | -19.21% | 0.59% | 5.78% |
Profit Margin | -19.41% | -13.21% | -16.15% | -0.63% | 4.42% |
Free Cash Flow Margin | - | -3.77% | -17.56% | 9.58% | 6.27% |
EBITDA | -436.95 | -411.95 | -389.29 | 263.16 | 471.37 |
EBITDA Margin | -13.12% | -8.61% | -12.07% | 4.35% | 11.10% |
D&A For EBITDA | 232.25 | 232.25 | 230.17 | 227.63 | 226.02 |
EBIT | -669.2 | -644.2 | -619.46 | 35.53 | 245.36 |
EBIT Margin | -20.10% | -13.47% | -19.21% | 0.59% | 5.78% |
Effective Tax Rate | - | - | - | - | 19.23% |
Revenue as Reported | - | 4,784 | 3,225 | 6,048 | 4,247 |
Advertising Expenses | - | 0.05 | 0.02 | 0.05 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.